Lipids in Health and Disease

Table 5 Results of hematological tests and hepatic and kidney function

From: Lactic-fermented egg white improves visceral fat obesity in Japanese subjects—double-blind, placebo-controlled study

		Intake Period (Weeks)
		0			6			12
WBC	Control	5683	±	334	6072	±	382	5972	±	327
(/μL)	LE	5779	±	310	5758	±	301	5579	±	290
RBC	Control	473	±	10	470	±	9	476	±	10
(/μL)	LE	488	±	11	480	±	10	491	±	9
Hb	Control	14.7	±	0.3	14.7	±	0.3	14.6	±	0.3
(g/dL)	LE	14.8	±	0.3	14.7	±	0.3	14.7	±	0.3
Ht	Control	44.4	±	0.9	44.9	±	0.8	44.6	±	0.8
(%)	LE	45.0	±	0.9	44.8	±	0.8	45.0	±	0.7
MCV	Control	93.9	±	0.6	95.7	±	0.8^a	93.9	±	0.7
(fl)	LE	92.3	±	0.7	93.5	±	0.8^a	91.8	±	0.7#
MCH	Control	31.1	±	0.3	31.2	±	0.3	30.8	±	0.3
(pg)	LE	30.3	±	0.3	30.6	±	0.3^a	30.1	±	0.3*
MCHC	Control	33.0	±	0.2	32.6	±	0.2^a	32.8	±	0.2
(%)	LE	32.8	±	0.2	32.7	±	0.2	32.7	±	0.1
Platelet	Control	23.8	±	1.4	23.0	±	0.9	22.7	±	0.9
(/μL)	LE	23.7	±	1.3	22.5	±	1.2	22.7	±	1.2
AST	Control	21.9	±	1.8	22.1	±	2.0	24.4	±	3.8
(IU/L)	LE	22.1	±	1.3	24.7	±	1.9	24.9	±	2.3
ALT	Control	27.9	±	4.2	27.2	±	4.2	30.8	±	7.1
(IU/L)	LE	25.0	±	2.1	39.8	±	3.2	28.0	±	2.5
γ-GTP	Control	49.2	±	12.2	48.0	±	11.1	42.4	±	9.1
(IU/L)	LE	42.7	±	9.2	44.3	±	8.9	40.6	±	7.3
BUN	Control	14.6	±	0.9	15.6	±	0.7	14.5	±	0.7
(mg/dL)	LE	13.8	±	0.9	15.9	±	0.8^a	15.2	±	0.7
Cr	Control	0.737	±	0.024	0.758	±	0.025	0.736	±	0.027
(mg/dL)	LE	0.839	±	0.032#	0.849	±	0.030#	0.853	±	0.035#
UA	Control	6.23	±	0.28	6.56	±	0.28	6.17	±	0.30
(mg/dL)	LE	6.32	±	0.24	6.49	±	0.23	6.18	±	0.24

Mean ± SE of 18 (control) and 19 (LE)
^ap < 0.05 vs. 0 weeks by Dunnett test、#p < 0.05 vs. Control by Student’s t-test
Control Control group, LE Lactic fermented egg white group

Back to article page

ISSN: 1476-511X

Contact us

General enquiries: journalsubmissions@springernature.com